UNIVERSITY OF CALIFORNIA SAN DIEGO
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1960-11-18
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucsd.edu
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
Phase 4
Active, not recruiting
- Conditions
- HivHormone Therapy
- Interventions
- First Posted Date
- 2020-11-05
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 64
- Registration Number
- NCT04616963
- Locations
- 🇺🇸
UC San Diego AntiViral Research Center (AVRC), San Diego, California, United States
Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor
Phase 1
Completed
- Conditions
- Hepatitis CHepatitis C Virus Infection, Response to Therapy of
- Interventions
- Drug: glecaprevir/pibrentasvir (GLE/PIB)
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 12
- Registration Number
- NCT04596475
- Locations
- 🇺🇸
University of California San Diego, San Diego, California, United States
Meditation Accelerated Brain Stimulation for Depression
Not Applicable
Active, not recruiting
- Conditions
- Depression
- Interventions
- Device: Medi2TMSDevice: Medi1TMS
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 50
- Registration Number
- NCT04586699
- Locations
- 🇺🇸
Neuromodulation Clinic Veterans Affairs San Diego, San Diego, California, United States
🇺🇸UC San Diego Health Psychiatry, San Diego, California, United States
Developing an EEG Paradigm to Study Prediction Error in Anorexia Nervosa
Not Applicable
Active, not recruiting
- Conditions
- Anorexia Nervosa
- Interventions
- Other: Prediction error tasks
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 47
- Registration Number
- NCT04583774
- Locations
- 🇺🇸
University of California San Diego, San Diego, California, United States
Optimizing Post-operative Recovery in Bariatric Patients With Obstructive Sleep Apnea Undergoing Outpatient Surgery: A Comparison of Sugammadex and Neostigmine
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 90
- Registration Number
- NCT04570150
- Locations
- 🇺🇸
University of California San Diego, La Jolla, California, United States
Neurofeedback to Improve Working Memory in Mild Cognitive Impairment
Not Applicable
Recruiting
- Conditions
- Mild Cognitive Impairment
- Interventions
- Other: PlaceboBehavioral: Neurofeedback
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 112
- Registration Number
- NCT04566900
- Locations
- 🇺🇸
University of California at San Diego, La Jolla, California, United States
Continuous Erector Spinae Plane Blocks for Rib Fractures
Phase 4
Terminated
- Conditions
- TraumaAnesthesiaAnesthesia, LocalRib Fractures
- Interventions
- Drug: Active ropivacaine 0.3% erector spinae plane perineural administrationDrug: Placebo erector spinae plane perineural administration
- First Posted Date
- 2020-09-22
- Last Posted Date
- 2023-06-12
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 4
- Registration Number
- NCT04558281
- Locations
- 🇺🇸
University California San Diego, San Diego, California, United States
Effect of Heat Stress on Global LV Function in Anesthetized Humans
Not Applicable
Completed
- Conditions
- HyperthermiaCardiac Functional Disturbances During Surgery
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2020-09-21
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 28
- Registration Number
- NCT04553900
- Locations
- 🇺🇸
University of California, San Diego, La Jolla, California, United States
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
- First Posted Date
- 2020-09-11
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 18
- Registration Number
- NCT04545710
- Locations
- 🇺🇸
UCSD Moores Cancer Center, La Jolla, California, United States
Combination GRA and SGLT-2i Treatment in Type 1 Diabetes
Phase 1
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2020-09-11
- Last Posted Date
- 2023-01-23
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 12
- Registration Number
- NCT04545411
- Locations
- 🇺🇸
UC San Diego Altman Clinical & Translational Research Institute, La Jolla, California, United States
© Copyright 2025. All Rights Reserved by MedPath